Shaping The Era of Digital Predicative Skin Analytics

The Team

Meet Our People

Mindera Health has assembled an Executive Team with a proven track record of both improving health economic outcomes and commercializing technology through IPOs, M&A, and transformative distribution agreements. The company is guided by a seasoned Board of Directors that includes Venture Capital firms, payer executive and public company leadership. Mindera Health is additionally assisted by influential luminaries who are universally respected guidelines authors. Together, this team is shaping the era of digital predictive skin analytics and leading the market in Dermal Intelligence™.

Leadership

Ron Rocca

President and Chief Executive Officer & Board Member

Kamal Adawi

Chief Financial Officer

Tobin Dickerson , PHD

Chief Scientific Officer and Co-founder

Scot Nelson

Sr. Director, Managed Markets

Steven D'Alessandro

Director, Sales

Board Of Directors

Samuel “BO” Bartholomew

CEO, EvidenceCare; Managing Partner, Rockmont Investments

Joseph Cook III

Managing Director, Mountain Group Partners

Tahir Mahmood, PHD

Co-founder, Mindera Health

Andrew Offer

Managing Director, Scientific Health Development

Deborah L. Rice- Johnsosn

CEO of Diversified Businesses for Highmark Inc.

Tyler Whitmore

Managing Director, Rippelos

Scientific Advisory Board

Dr. Alan Menter, MD – Chairman

Co-Chair, AAD/NPF guidelines

Bruce E. Strober MD, PHD

Board, Int'l Psoriasis Council

Mark Lebwohl

Chairman of Nat'l Psoriasis Foundation Med. Board

David M. Pariser, MD, FACP, FAAD

Former President, AAD

Craig L. Leonardi, MD

Board, Int'l Psoriasis Council

April W. Armstrong

MD, MPH Professor of Dermatology